Attach to Form 990 or Form 990-EZ.
See separate instructions.| (i) Name of supported organization |
(ii) EIN |
(iii) Type of organization (described on lines 1- 9 above or IRC section (see instructions)) |
(iv) Is the organization in col. (i) listed in your governing document? |
(v) Did you notify the organization in col. (i) of your support? |
(vi) Is the organization in col. (i) organized in the U.S.? |
(vii) Amount of support? |
|||
|---|---|---|---|---|---|---|---|---|---|
| Yes | No | Yes | No | Yes | No | ||||
| (1)
GROUP HEALTH PLAN INC |
410797853 | 170(B)(1) (A)(III) | Yes | 0 | |||||
| (2)
REGIONS HOSPITAL |
410956618 | 170(B)(1) (A)(III) | Yes | 0 | |||||
| Total | 0 | ||||||||
| Calendar year(or fiscal year beginning in) | (a) 2006 | (b) 2007 | (c) 2008 | (d) 2009 | (e) 2010 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") .... | ||||||
| 2 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf....... | ||||||
| 3 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | ||||||
| 4 | Total. Add lines 1 through 3.. | ||||||
| 5 | The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f).. | ||||||
| 6 | Public Support. Subtract line 5 from line 4. | ||||||
| Calendar year(or fiscal year beginning in) | (a) 2006 | (b) 2007 | (c) 2008 | (d) 2009 | (e) 2010 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 7 | Amounts from line 4.. | ||||||
| 8 | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. | ||||||
| 9 | Net income from unrelated business activities, whether or not the business is regularly carried on.. | ||||||
| 10 | Other income. (Explain in Part IV.) Do not include gain or loss from the sale of capital assets.. | ||||||
| 11 | Total support (Add lines 7 through 10). | ||||||






| Calendar year(or fiscal year beginning in) | (a) 2006 | (b) 2007 | (c) 2008 | (d) 2009 | (e) 2010 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") . | ||||||
| 2 | Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose...... | ||||||
| 3 | Gross receipts from activities that are not an unrelated trade or business under section 513.. | ||||||
| 4 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf... | ||||||
| 5 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | ||||||
| 6 | Total. Add lines 1 through 5. | ||||||
| 7a | Amounts included on lines 1, 2, and 3 received from disqualified persons... | ||||||
| b | Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year. | ||||||
| c | Add lines 7a and 7b.. | ||||||
| 8 | Public Support (Subtract line 7c from line 6.) | ||||||
| Calendar year (or fiscal year beginning in) | (a) 2006 | (b) 2007 | (c) 2008 | (d) 2009 | (e) 2010 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 9 | Amounts from line 6... | ||||||
| 10a | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. | ||||||
| b | Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975. | ||||||
| c | Add lines 10a and 10b. | ||||||
| 11 | Net income from unrelated business activities not included in line 10b, whether or not the business is regularly carried on. | ||||||
| 12 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part IV.) | ||||||
| 13 | Total support (Add lines 9, 10c, 11 and 12.). | ||||||




| Facts And Circumstances Test |
|---|
| Explanation |
|---|
| Software ID: | |
| Software Version: |
Attach to Form 990 or 990-EZ.| Identifier | Return Reference | Explanation |
|---|---|---|
| EXEMPT PURPOSE AND ACHIEVEMENTS | FORM 990, PART III, LINE 4A | I. ORGANIZATION AND GOVERNANCE THE HEALTHPARTNERS RESEARCH FOUNDATION (HPRF) IS A MINNESOTA NONPROFIT CORPORATION RECOGNIZED AS EXEMPT FROM FEDERAL INCOME TAX UNDER INTERNAL REVENUE CODE (IRC) SECTION 501(C)(3). HPRF IS RECOGNIZED AS A PUBLIC CHARITY UNDER IRC SECTION 509(A)(3) AS A SUPPORTING ORGANIZATION TO GROUP HEALTH PLAN, INC. (GHI), A MINNESOTA NONPROFIT CORPORATION AND LICENSED HEALTH MAINTENANCE ORGANIZATION (HMO), AND TO REGIONS HOSPITAL, A MINNESOTA NONPROFIT CORPORATION AND LICENSED HOSPITAL, BOTH OF WHICH ARE RECOGNIZED AS EXEMPT FROM FEDERAL INCOME TAX UNDER IRC SECTION 501(C)(3). FOR INFORMATION ABOUT THE CHARITABLE AND COMMUNITY BENEFIT ACTIVITIES AND ACCOMPLISHMENTS OF HPRF'S SUPPORTED ORGANIZATIONS, SEE THE FORM 990 ANNUAL FILINGS FOR EACH ENTITY. HPRF IS PART OF THE HEALTHPARTNERS FAMILY OF ORGANIZATIONS. SPECIFICALLY, THE SOLE CORPORATE MEMBER OF HPRF IS GHI. GHI IS ALSO THE SOLE CORPORATE MEMBER OF HEALTHPARTNERS CENTRAL MINNESOTA CLINICS, INC. (FORMERLY CENTRAL MINNESOTA GROUP HEALTH, INC.), AND PHYSICIANS NECK & BACK CLINICS, BOTH OF WHICH ARE MINNESOTA NONPROFIT CORPORATIONS RECOGNIZED AS EXEMPT FROM FEDERAL INCOME TAX UNDER IRC SECTION 501(C)(3). HEALTHPARTNERS, INC., A MINNESOTA NONPROFIT CORPORATION AND LICENSED HMO RECOGNIZED AS EXEMPT FROM FEDERAL INCOME TAX UNDER IRC SECTION 501(C)(4), IS THE SOLE CORPORATE MEMBER OF GHI AND ALSO OF THE FOLLOWING ORGANIZATIONS, WHICH ARE ALSO EXEMPT FROM FEDERAL INCOME TAX UNDER IRC SECTION 501(C)(3): HEALTHPARTNERS INSTITUTE FOR MEDICAL EDUCATION, RHSC, INC., AND HPI-RAMSEY. HPI-RAMSEY IS THE SOLE CORPORATE MEMBER OF REGIONS HOSPITAL, REGIONS HOSPITAL FOUNDATION, CAPITAL VIEW TRANSITIONAL CARE CENTER (FORMERLY NORTH ST. PAUL TRANSITIONAL CARE CENTER) AND RAMSEY INTEGRATED HEALTH SERVICES (A HOME CARE AGENCY), ALL OF WHICH ARE MINNESOTA NONPROFIT CORPORATIONS EXEMPT FROM FEDERAL INCOME TAX UNDER IRC SECTION 501(C)(3). HPI-RAMSEY IS ALSO THE SOLE CORPORATE MEMBER OF RH-WISCONSIN, INC., A WISCONSIN NON-STOCK CORPORATION EXEMPT FROM FEDERAL INCOME TAX UNDER IRC SECTION 501(C)(3). RH-WISCONSIN, INC. AND GHI ARE CORPORATE MEMBERS OF HUDSON HOSPITAL, INC. AND WESTFIELDS HOSPITAL, INC., WISCONSIN NONPROFIT CORPORATIONS EXEMPT FROM FEDERAL INCOME TAX UNDER IRC SECTION 501(C)(3). RH-WISCONSIN, INC. IS ALSO THE SOLE CORPORATE MEMBER OF WESTERN WISCONSIN EMERGENCY MEDICAL SERVICES COMPANY, AN AMBULANCE SERVICE WHICH IS A WISCONSIN NON-PROFIT CORPORATION EXEMPT FROM FEDERAL INCOME TAX UNDER IRC SECTION 501(C)(3). TOGETHER, THESE CORPORATIONS AND OTHERS FORM THE HEALTHPARTNERS FAMILY OF ORGANIZATIONS. THE HEALTHPARTNERS FAMILY OF EXEMPT ORGANIZATIONS SEEKS TO BE THE BEST AND MOST TRUSTED PROVIDER OF HEALTH CARE, HEALTH PROMOTION, HEALTH CARE FINANCING, AND HEALTH CARE ADMINISTRATION IN THE UNITED STATES. ACTING IN CONCERT, THIS FAMILY OF ORGANIZATIONS INTENDS TO TRANSFORM HEALTH CARE BY DELIVERING OUTSTANDING CARE AND SERVICE CONSISTENT WITH THE "TRIPLE AIM." THE TRIPLE AIM IS AN INITIATIVE OF THE INSTITUTE FOR HEALTHCARE IMPROVEMENT TO HELP HEALTH CARE ORGANIZATIONS SIMULTANEOUSLY IMPROVE THE INDIVIDUAL EXPERIENCE OF CARE, THE HEALTH OF THE POPULATION, AND THE PER-CAPITA COST OF CARE. HPRF WORKS WITH AND SUPPORTS CERTAIN EXEMPT ORGANIZATIONS WITHIN THE HEALTHPARTNERS FAMILY OF ORGANIZATIONS TO ACHIEVE THESE AIMS WITH MAXIMUM EFFICIENCY AND COLLABORATION. FORMED IN 1998 BY THE MERGER OF GROUP HEALTH FOUNDATION AND RAMSEY FOUNDATION, HPRF CONTINUES TO BUILD ON THE LONG HISTORY OF RESEARCH ESTABLISHED BY THE TWO PREVIOUS FOUNDATIONS. HPRF AND THE HEALTHPARTNERS FAMILY OF ORGANIZATIONS ALSO PARTNER WITH HMOS, CARE PROVIDERS, AND NONPROFIT ORGANIZATIONS THROUGHOUT THE REGION AND THE NATION TO INCREASE ACCESS FOR THE UNDERSERVED, CREATE AND DISSEMINATE RESEARCH AND CARE-IMPROVEMENT INFORMATION, PARTICIPATE IN THE DEVELOPMENT OF PUBLIC POLICY, AND MAXIMIZE SHARED RESOURCES FOR THE IMPROVEMENT OF THE HEALTH CARE SYSTEM AND THE COMMUNITY'S OVERALL HEALTH. II. RESEARCH ACTIVITIES HPRF'S MISSION IS TO DISCOVER AND ACCELERATE THE USE OF KNOWLEDGE TO IMPROVE THE HEALTH AND HEALTH CARE OF OUR MEMBERS, PATIENTS, AND COMMUNITY. HPRF SEEKS TO IMPROVE HEALTH AND HEALTH CARE THROUGH THE IMPLEMENTATION OF RESEARCH FINDINGS. RESEARCH AREAS OF FOCUS IN HPRF ARE HEALTH BEHAVIORS, CHRONIC DISEASE, MENTAL HEALTH, NEUROSCIENCE AND ALZHEIMER'S DISEASE, AND ORAL HEALTH AND DENTAL CARE. IN 2010, HPRF WAS INVOLVED IN MORE THAN 200 RESEARCH PROJECTS. AN OVERVIEW OF SOME PROJECT AREAS FOLLOWS. |
| HEALTH BEHAVIORS IN 2010, HPRF CONDUCTED THE FOLLOWING STUDIES FOCUSED ON HEALTH BEHAVIOR: - HEALTH OUTCOMES OF BARIATRIC SURGERY IN INDIVIDUALS WITH TYPE 2 DIABETES - THIS MULTI-CENTER STUDY USES EXISTING DATA TO EXAMINE SHORT- AND LONG-TERM DIABETES-SPECIFIC OUTCOMES FOR INDIVIDUALS WITH TYPE 2 DIABETES WHO HAVE UNDERGONE BARIATRIC SURGERY VS. INDIVIDUALS WHO HAVE BEEN TREATED EXCLUSIVELY WITH USUAL CARE (I.E., ORAL AGENTS AND/OR INSULIN OR ORAL AGENTS PLUS INSULIN). IT IS FUNDED BY THE AGENCY FOR HEALTHCARE RESEARCH AND QUALITY. - OBESITY PREVENTION IN CHILDREN - FUNDED BY THE NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASE, THE "HEALTHY HOMES/HEALTHY KIDS: PEDIATRIC PRIMARY CARE-BASED OBESITY PREVENTION" STUDY EVALUATES THE LONG-TERM EFFICACY OF A PEDIATRIC PRIMARY CARE-BASED OBESITY-PREVENTION INTERVENTION FOR AT-RISK 5- TO 9-YEAR-OLD CHILDREN. A SIMILAR STUDY FUNDED BY THE NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASE IN AT-RISK PRESCHOOL-AGE CHILDREN IS ALSO ONGOING. - MAINTAINING WEIGHT LOSS - "KEEP IT OFF," AN ONGOING STUDY THAT BEGAN IN 2006, IS FUNDED WITH A $1.75 MILLION GRANT FROM THE NATIONAL CANCER INSTITUTE TO STUDY HOW PEOPLE CAN MAINTAIN WEIGHT LOSS OVER THE LONG TERM. THE STUDY IDENTIFIES THE MOST SUCCESSFUL METHODS FOR ADULTS WHO HAVE LOST 10 PERCENT OF THEIR BODY WEIGHT IN THE PAST YEAR TO MAINTAIN THEIR NEW, HEALTHIER WEIGHT. - COMMUNITY-SUPPORTED AGRICULTURE (CSA) - CSA IS A PRACTICE IN WHICH INTERESTED CONSUMERS PURCHASE A SHARE, OR MEMBERSHIP, FROM A LOCAL FARMER AND IN RETURN RECEIVE A BOX OF SEASONAL PRODUCE EACH WEEK THROUGHOUT THE FARMING SEASON. FUNDED BY AN INTERNAL GRANT, THE "A NOVEL DIETARY IMPROVEMENT INCENTIVE STRATEGY?: EXAMINING THE POTENTIAL IMPACT OF COMMUNITY-SUPPORTED AGRICULTURE MEMBERSHIP" IS EXAMINING THE FEASIBILITY AND ACCEPTABILITY OF PROMOTING CSA MEMBERSHIPS IN WORKSITES. THE PROGRAM ALSO EXAMINES THE IMPACT OF CSA MEMBERSHIP ON DIETARY INTAKE AND MODIFIABLE HEALTH POTENTIAL SCORES AMONG EMPLOYEES AND FAMILY MEMBERS. - PREVENTIVE SERVICES THAT IMPROVE HEALTH BEHAVIORS - UNDER THE GUIDANCE OF THE NATIONAL COMMISSION ON PREVENTION PRIORITIES AND IN COLLABORATION WITH THE PARTNERSHIP FOR PREVENTION, TWO STUDIES ARE DEFINING THE VALUE OF PREVENTIVE SERVICES THAT IMPROVE HEALTH BEHAVIORS. "PRIORITIES FOR CLINICAL PREVENTIVE SERVICES," NOW IN ITS 11TH YEAR, AND "MEASURING AND COMPARING THE VALUE OF COMMUNITY PREVENTIVE SERVICES," WHICH BEGAN IN 2008, GUIDE DECISION MAKERS ABOUT THE RELATIVE VALUE OF PREVENTIVE INTERVENTIONS. CHRONIC DISEASE DIABETES, HYPERTENSION AND CARDIOVASCULAR RISK REDUCTION IS AN AREA OF STRENGTH IN HPRF. IN 2010, HPRF INVESTIGATORS LED AND WERE INVOLVED IN THE FOLLOWING STUDIES: DIABETES - SIMULATED DIABETES TRAINING FOR RESIDENT PHYSICIANS - THIS STUDY AIMS TO IMPROVE THE SAFETY AND EFFECTIVENESS OF DIABETES CARE DELIVERED BY PRIMARY CARE RESIDENTS THROUGH AN INNOVATIVE SIMULATED LEARNING INTERVENTION THAT OVERCOMES A NUMBER OF CURRENT OBSTACLES TO OUTPATIENT DIABETES CARE TRAINING IN PRIMARY CARE RESIDENCY PROGRAMS. - INTERACTIVE DIALOG TO EDUCATE AND ACTIVATE (IDEA) - THIS STUDY IS INVESTIGATING VARIOUS METHODS FOR EDUCATING INDIVIDUALS WITH DIABETES AND EVALUATING WHICH METHODS LEAD TO IMPROVED HEALTH OUTCOMES. PATIENT BEHAVIORAL CHANGE AND EMPOWERMENT FOR SELF-MANAGEMENT ACTIVITIES ARE KEY FACTORS IN IMPROVING DIABETES CARE, BUT FEW PATIENTS CURRENTLY RECEIVE THE SUPPORT THEY NEED TO ATTAIN SELF-EFFICACY. - ACTION TO CONTROL CARDIOVASCULAR RISK IN DIABETES (ACCORD) - THIS TRIAL, FUNDED BY THE NATIONAL INSTITUTES OF HEALTH (NIH), IS ONE OF THE LARGEST TYPE 2 DIABETES STUDIES IN HISTORY, WITH MORE THAN 10,000 PATIENTS ENROLLED IN THE UNITED STATES AND CANADA. IT EVALUATES WHETHER MORE INTENSIVE STRATEGIES THAN THE CURRENT STANDARD OF CARE IN THREE CLINICAL DOMAINS (BLOOD SUGAR, BLOOD PRESSURE, AND CHOLESTEROL) CAN REDUCE THE RATE OF MAJOR CARDIOVASCULAR DISEASE MORBIDITY AND MORTALITY ASSOCIATED WITH TYPE 2 DIABETES. TRIAL PARTICIPANTS ARE MIDDLE-AGED OR OLDER PEOPLE WITH TYPE 2 DIABETES WHO ARE AT HIGH RISK FOR A CARDIOVASCULAR EVENT. - HEALTH OUTCOMES OF BARIATRIC SURGERY IN INDIVIDUALS WITH TYPE 2 DIABETES - THIS MULTI-CENTER STUDY USES EXISTING DATA TO EXAMINE SHORT- AND LONG-TERM DIABETES-SPECIFIC OUTCOMES FOR INDIVIDUALS WITH TYPE 2 DIABETES WHO HAVE UNDERGONE BARIATRIC SURGERY VS. INDIVIDUALS WHO HAVE BEEN TREATED EXCLUSIVELY WITH USUAL CARE (I.E., ORAL AGENTS AND/OR INSULIN OR ORAL AGENTS PLUS INSULIN). IT IS FUNDED BY THE AGENCY FOR HEALTHCARE RESEARCH AND QUALITY. - SUPREME - BUILDING NEW CLINICAL INFRASTRUCTURE FOR COMPARATIVE EFFECTIVENESS RESEARCH. WE PROPOSE TO ADDRESS THE QUESTION OF WHETHER INTENSIVE GLYCEMIC CONTROL IN ADULT PATIENTS WITH TYPE 2 DIABETES LEADS TO IMPROVED SHORT- AND LONGER-TERM OUTCOMES COMPARED WITH LESS INTENSIVE THERAPY AND TO DETERMINE WHETHER ITS BENEFIT VARIES AS A FUNCTION OF AGE, PRIOR CARDIOVASCULAR DISEASE, BLOOD PRESSURE OR LDL CHOLESTEROL CONTROL. THIS WILL BE DONE USING OBSERVATIONAL LONGITUDINAL ANALYSES WITHIN A POOLED CLINICAL COHORT OF 500,000 PATIENTS AND SECONDARY ANALYSES USING AN INSTRUMENTAL VARIABLE. - EFFECTIVENESS OF IMMEDIATE VS. DELAYED METFORMIN USE IN NEWLY DIAGNOSED DIABETES - THIS STUDY WILL EXAMINE THE COMPARATIVE EFFECTIVENESS OF IMMEDIATE INITIATION OF METFORMIN MONOTHERAPY VS. DELAYED INITIATION OF METFORMIN OR EARLY/LATE INITIATION OF SULFONYLUREA MONOTHERAPY FOR A VARIETY OF OUTCOMES. USING EMR DATA FROM FOUR LARGE HEALTH SYSTEM MEMBERS OF THE HMO RESEARCH NETWORK DIABETES CONSORTIUM, WE WILL CREATE A LARGE COHORT OF NEWLY DIAGNOSED TYPE 2 DIABETIC PATIENTS WITH AVERAGE FOLLOWUP OF 3.5 YEARS. IN LONGITUDINAL ANALYSES, THE INVESTIGATORS WILL EXAMINE WHETHER PROMPT INITIATION OF METFORMIN (WITHIN 6 MONTHS OF THE EARLIEST DETECTION OF DIABETES) COMPARED WITH OTHER STRATEGIES IS ASSOCIATED WITH MULTIPLE CLINICAL INDICATORS. | ||
| HYPERTENSION - PEDIATRIC HYPERTENSION AND OBESITY - A MULTICENTER STUDY TO EXAMINE PREDICTORS OF AND PATTERNS OF CARE REGARDING PEDIATRIC HYPERTENSION AND OBESITY. IT BEGAN IN 2009 AND IS FUNDED BY THE NATIONAL HEART, LUNG AND BLOOD INSTITUTE. - SIMCARE HYPERTENSION - A "PERSONALIZED PHYSICIAN LEARNING" APPROACH THAT ASSESSES THE IMPACT OF TWO INTERVENTIONS FOR REDUCING HYPERTENSION IN A PRIMARY CARE SETTING. PHYSICIANS ARE ASSIGNED 12 SIMULATED LEARNING CASES THAT CORRESPOND TO HYPERTENSION TREATMENT FAILURES THAT ARE IDENTIFIED USING TWO DISTINCT METHODOLOGIES. THE LEARNING CASES ARE DELIVERED VIA THE WEB, EMBODY PRINCIPLES OF ADAPTIVE LEARNING, AND PROVIDE THREE KINDS OF LEARNING FEEDBACK (LEARNING BY DOING, GRAPHIC DATA DISPLAYS, AND SPECIFIC CLINICAL MANAGEMENT SUGGESTIONS). THIS PROJECT IS FUNDED BY THE NATIONAL HEART, LUNG AND BLOOD INSTITUTE. - CVRN MH- THE PROPOSAL WILL LEVERAGE THE UNIQUE MULTI-CENTER RESEARCH COLLABORATION OF CVRN WITH PARTICIPATING SITES CONTRIBUTING COMPLEMENTARY EXPERTISE AND COLLECTIVELY VERY LARGE, DIVERSE POPULATIONS. THE WORK WILL EXAMINE THE RELATION BETWEEN THREE PREVALENT MENTAL HEALTH DISORDERS (DEPRESSION, ANXIETY DISORDERS, AND ADHD), THEIR ASSOCIATED THERAPIES, AND OUTCOMES FOR HYPERTENSION, ATRIAL FIBRILLATION AND VENOUS THROMBOEMBOLIC DISEASE WITHIN THE NHLBI-SPONSORED CVRN. THESE OUTCOMES WILL INCLUDE INTERMEDIATE MARKERS SUCH AS MEDICATION ADHERENCE AND SURROGATE OUTCOMES, AS WELL AS LONG-TERM CLINICAL OUTCOMES. - DECIDE NETWORK THIS IS AN AHRQ-FUNDED PROJECT THAT WILL CREATE AN OPERATING NATIONAL RESEARCH DATA NETWORK THROUGH STATE-OF-THE-ART COMMUNICATION BETWEEN MULTIPLE CARED DELIVERY ORGANIZATIONS AROUND THE COUNTRY. A SUBPROJECT IS ANALYSIS OF PROCESS AND OUTCOME OF CARE DATA USING CER ANALYTIC METHODS WITHIN A LARGE COHORT OF APPROXIMATELY 500,000 ADULTS WITH HYPERTENSION. - AIM-HIGH - A LARGE, MULTISITE RANDOMIZED CONTROL TRIAL FUNDED BY THE UNITED STATES NATIONAL HEART, LUNG, AND BLOOD INSTITUTE (PART OF THE NIH) WITH SUPPORT FROM ABBOTT LABORATORIES. THIS STUDY EVALUATES WHETHER ADDING NIASPAN TO THE STANDARD CHOLESTEROL-MANAGEMENT APPROACH OF LOWERING LOW-DENSITY LIPOPROTEIN (LDL, OR "BAD") CHOLESTEROL WITH STATIN THERAPY WILL FURTHER REDUCE THE RISK OF HEART ATTACKS, STROKE, AND OTHER HEART-RELATED COMPLICATIONS FOR PATIENTS WITH PRE-EXISTING HEART DISEASE OR STROKES. NIASPAN IS A U.S. FOOD AND DRUG ADMINISTRATION-APPROVED DRUG THAT RAISES HIGH-DENSITY LIPOPROTEIN (HDL, OR "GOOD") CHOLESTEROL AND LOWERS TRIGLYCERIDES. - PEDIATRIC HYPERTENSION IN EMRS - A MULTICENTER STUDY TO EXAMINE PREDICTORS OF AND PATTERNS OF CARE REGARDING PEDIATRIC HYPERTENSION. IT BEGAN IN 2009 AND IS FUNDED BY THE NATIONAL HEART, LUNG AND BLOOD INSTITUTE. - SIMCARE HYPERTENSION - A "PERSONALIZED PHYSICIAN LEARNING" APPROACH THAT ASSESSES THE IMPACT OF TWO INTERVENTIONS FOR REDUCING HYPERTENSION IN A PRIMARY CARE SETTING. THE FIRST INTERVENTION, REAL-PPL, USES REAL EMR-DERIVED DATA TO DIRECT PERSONALIZED LEARNING. THE SECOND INTERVENTION, SIM-PPL, USES PHYSICIAN PERFORMANCE IN SIMULATED CASES. THE REAL-PPL AND SIM-PPL ASSESSMENT DATA ARE USED TO IDENTIFY EACH PHYSICIAN'S PATTERN OF THERAPEUTIC INERTIA AND FAILURES OF DECISION MAKING IN HYPERTENSION. PHYSICIANS ARE THEN ASSIGNED AND DELIVERED 12 SIMULATED HYPERTENSION LEARNING CASES THAT CORRESPOND TO THE TREATMENT FAILURES IDENTIFIED. THE LEARNING CASES ARE DELIVERED VIA THE WEB, EMBODY PRINCIPLES OF ADAPTIVE LEARNING, AND PROVIDE THREE KINDS OF LEARNING FEEDBACK (ACTUAL BLOOD PRESSURE VALUES, GRAPHIC DATA DISPLAYS, AND SPECIFIC CLINICAL MANAGEMENT SUGGESTIONS). CARDIOVASCULAR - PRIORITIZED CLINICAL DECISION SUPPORT TO REDUCE CARDIOVASCULAR RISK- THE OBJECTIVE OF THIS PROJECT IS TO DEVELOP AND IMPLEMENT POINT-OF-CARE EHR-DRIVEN DECISION SUPPORT THAT IDENTIFIES AND PRIORITIZES AVAILABLE EVIDENCE-BASED CLINICAL OPTIONS TO REDUCE CV RISK IN MODERATE TO HIGH RISK ADULTS. THIS APPROACH, IF SUCCESSFUL, WILL (A) IMPROVE CHRONIC DISEASE OUTCOMES, (B) USHER IN THE COMING ERA OF PERSONALIZED MEDICINE, (C) MAXIMIZE THE CLINICAL RETURN ON THE MASSIVE INVESTMENTS THAT ARE INCREASINGLY BEING MADE IN SOPHISTICATED OUTPATIENT EHR SYSTEMS, AND (D) REDUCE THE "PIPELINE" OF CV RISK IN ORDER TO SUSTAIN DECADES-LONG IMPROVEMENT TRENDS IN CV EVENTS AND CV MORTALITY IN THE UNITED STATES. THIS PROJECT IS FUNDED BY THE NATIONAL HEART, LUNG AND BLOOD INSTITUTE. TREATMENT OF PULMONARY CONDITIONS AND DISEASE IN 2010, HPRF PULMONARY SPECIALISTS PARTICIPATED IN THE CHRONIC PULMONARY DISEASE CLINICAL RESEARCH NETWORK, A CONSORTIUM OF 10 CLINICAL CENTERS AND A COORDINATING CENTER AT THE UNIVERSITY OF MINNESOTA. ACTIVE STUDIES INCLUDE: - A CLINICAL TRIAL EXAMINING THE EFFECTS OF GIVING A DAILY DOSE OF THE MACROLIDE ANTIBIOTIC AZITHROMYCIN TO PATIENTS WITH MODERATE TO SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD). - THE NIH-FUNDED STUDY "MULTICOMPONENT INTERVENTION TO DECREASE CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)-RELATED HOSPITALIZATIONS." - THE "PROSPECTIVE RANDOMIZED PLACEBO-CONTROLLED TRIAL OF SIMVASTATIN IN THE PREVENTION OF COPD EXACERBATIONS (STATCOPE)," ALSO FUNDED BY THE NIH - AN OBSERVATIONAL STUDY FUNDED BY THE NIH DESIGNED TO DISCOVER GENETIC FACTORS THAT MIGHT PREDICT COPD. THE RESEARCHERS ARE ALSO ASSESSING GENETIC FACTORS ASSOCIATED WITH OTHER SMOKING-RELATED DISORDERS (EG, CANCER, HEART/VASCULAR DISEASE). RESULTS ARE EXPECTED IN 2011. DEPRESSION CARE PROVIDING CARE FOR DEPRESSION IS AN IMPORTANT PART OF MEDICAL CARE. IN 2010, HPRF RESEARCHERS WERE ACTIVE IN SEVERAL IMPORTANT STUDIES, INCLUDING "DIABETES AND DEPRESSION" (HIGHLIGHTED PREVIOUSLY) AND "DEPRESSION IMPROVEMENT ACROSS MINNESOTA, OFFERING A NEW DIRECTION (DIAMOND)." - THE DIAMOND STUDY - A COMPREHENSIVE EVALUATION OF A GROUNDBREAKING INITIATIVE TO CHANGE THE WAY MINNESOTANS RECEIVE TREATMENT FOR DEPRESSION. THE NATIONAL INSTITUTE OF MENTAL HEALTH AWARDED HPRF A $3 MILLION GRANT FOR DIAMOND, WHICH IS LED BY MINNESOTA'S INSTITUTE FOR CLINICAL SYSTEMS IMPROVEMENT. COMPONENTS OF THE NEW PROGRAM INCLUDE USE OF A STANDARD ASSESSMENT TOOL TO IMPROVE THE DIAGNOSIS AND MANAGEMENT OF DEPRESSION, THE ADDITION OF A CARE MANAGER TO THE PATIENT'S TREATMENT TEAM FOR MORE PERSONALIZED CARE, AND A TRACKING SYSTEM TO MONITOR FOLLOW-UP CARE AND TREATMENT EFFECTIVENESS. THE DIAMOND DEPRESSION CARE MODEL WAS IMPLEMENTED IN ABOUT 85 PRIMARY CARE MEDICAL CLINICS ACROSS MINNESOTA IN 2008 AND 2009. DIAMOND IS LED BY HPRF IN CLOSE PARTNERSHIP WITH DIAMOND INITIATIVE LEADERS AND NATIONAL RESEARCH EXPERTS. THE STUDY IS EVALUATING CHANGES IN PATIENT CARE, PATIENT OUTCOMES, PATIENT CARE COST AND UTILIZATION, THE COST TO CLINICS AND HEALTH PLANS TO IMPLEMENT THE CARE MODEL, AND CLINIC FACTORS IMPORTANT TO SUCCESS. RESULTS ARE EXPECTED IN 2011. NEUROSCIENCE AND ALZHEIMER'S DISEASE RESEARCH HPRF'S ALZHEIMER'S RESEARCH CENTER AT REGIONS HOSPITAL IS INTERNATIONALLY KNOWN FOR ITS PIONEERING RESEARCH ON THE TREATMENT AND PREVENTION OF ALZHEIMER'S DISEASE, PARKINSON'S DISEASE, STROKE, AND OTHER BRAIN DISORDERS. IN 2010, ALZHEIMER'S RESEARCH CENTER INVESTIGATORS PUBLISHED 11 PAPERS IN SCIENTIFIC JOURNALS. 15 STUDIES ARE CURRENTLY IN PROGRESS. THE ALZHEIMER RESEARCH CENTER, WHICH MAINTAINS ONE OF THE WORLD'S LARGEST HUMAN BRAIN BANKS FOR RESEARCH, FOCUSES ON CLINICAL TRIALS, THE DEVELOPMENT OF A PATIENT REGISTRY TO STUDY MEMORY, AND THE DEVELOPMENT OF DRUGS AND DRUG-DELIVERY METHODS (EG, NOSE DROPS, INTRANASAL SPRAYS). THIS DELIVERY METHOD PROTECTS THE PARTS OF THE BRAIN ESSENTIAL FOR MEMORY AND LEARNING WHILE AVOIDING THE SIDE EFFECTS OF OTHER METHODS. CENTER RESEARCHERS COLLABORATE WITH 40 RESEARCHERS WORLDWIDE WHO ARE USING THE INTRANASAL TREATMENT METHOD IN THEIR OWN RESEARCH. THE ALZHEIMER'S RESEARCH CENTER'S ABILITY TO CONDUCT RESEARCH WITH HUMANS IS ENHANCED BY ITS RELATIONSHIP WITH THE CENTER FOR DEMENTIA AND ALZHEIMER'S CARE (CDAC) IN REGIONS HOSPITAL AND HEALTHPARTNERS. HUMAN CLINICAL TRIALS BEGAN AT CDAC IN 2010. | ||
| EXAMPLES OF CURRENT WORK AT THE ALZHEIMER'S RESEARCH CENTER INCLUDE: - STUDIES OF DRUGS GIVEN INTRANASALLY (EG, DEFEROXAMINE, INSULIN, AL-108, STEM CELLS) TO SLOW COGNITIVE DECLINE IN ALZHEIMER'S DISEASE. THE CENTER'S INTRANASAL DEFEROXAMINE TREATMENT IS EXPECTED TO BE MARKETED FOR THE TREATMENT OF ALZHEIMER'S IN THE NEXT 5 YEARS AS A RESULT OF AN AGREEMENT WITH A CANADIAN PHARMACEUTICAL COMPANY. THIS DRUG IS ALSO BEING STUDIED AS A TREATMENT FOR OTHER NEUROLOGICAL DISORDERS, SUCH AS STROKE. - THE CENTER COMPLETED A STUDY PARTIALLY FUNDED BY THE NIH ON THE EFFICACY OF FOUR LIFESTYLE CHOICES (PHYSICAL, SOCIAL, MENTAL ACTIVITY, AND NUTRITION) IN PREVENTING MEMORY LOSS DURING AGING. THE STUDY FOLLOWED 63 NORMAL-FUNCTIONING ADULTS AGES 60 TO 80. RESULTS ARE BEING ANALYZED. - HPRF, THE CENTER FOR SPIRITUALITY AND HEALING AT THE UNIVERSITY OF MINNESOTA, THE ALZHEIMER'S RESEARCH CENTER, AND SENIOR COMMUNITY SERVICES, BEGAN A RESEARCH STUDY THAT EXAMINES WAYS TO HELP FAMILY MEMBERS COPE WHEN A MEMBER HAS DEMENTIA. THE "BALANCE" STUDY, WHICH WAS COMPLETED IN 2010, REVIEWS TWO DIFFERENT APPROACHES: A SUPPORT GROUP FORMAT AND AN INDIVIDUALIZED STRESS-REDUCTION TECHNIQUE CLASS. RESULTS ARE EXPECTED IN 2011. ORAL HEALTH AND DENTISTRY HPRF RESEARCHERS WERE ACTIVE IN 22 STUDIES IN 2010, 17 OF THEM THROUGH THE DENTAL PRACTICE-BASED RESEARCH NETWORK (DPBRN), FUNDED THROUGH THE NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH, PART OF THE NIH. THE DPBRN IS CONDUCTING THE FOLLOWING RESEARCH IN THE REAL-WORLD SETTINGS OF DENTAL OFFICES: - "ASSESSMENT OF CARIES DIAGNOSIS AND TREATMENT" - "REASONS FOR PLACING THE FIRST RESTORATION ON PERMANENT TOOTH SURFACES" - "REASONS FOR REPLACEMENT OR REPAIR OF DENTAL RESTORATIONS" - "CONDOR STUDY OF OSTEONECROSIS OF THE JAWS" - "HYGIENISTS TO INTERNET QUALITY IMPROVEMENT IN TOBACCO (HI-QUIT)" - "LONGITUDINAL STUDY OF DENTAL RESTORATIONS PLACED ON PREVIOUSLY UNRESTORED SURFACES" - "LONGITUDINAL STUDY OF REPAIRED OR REPLACED DENTAL RESTORATIONS" - "PATIENT SATISFACTION WITH DENTAL RESTORATIONS" - "PREVALENCE OF QUESTIONABLE OCCLUSAL CARIES LESIONS" - "LONGITUDINAL STUDY OF QUESTIONABLE OCCLUSAL CARIES LESIONS" - "RETROSPECTIVE COHORT STUDY OF OSTEONECROSIS OF THE JAWS" - "ASSESSING IMPACT OF PARTICIPATION IN PRACTICE-BASED RESEARCH ON CLINICAL PRACTICE & PATIENT CARE" - "PERI-OPERATIVE PAIN & ROOT CANAL THERAPY" - "PERSISTENT PAIN & ROOT CANAL THERAPY" - "PRIMARY CARE MANAGEMENT FOR TMJ-D PAIN" - "BLOOD SUGAR TESTING IN DENTAL PRACTICE" - "INFRASTRUCTURE UPDATE SURVEY" ON DPBRN PRACTITIONER ENROLLMENT INFORMATION LOCAL STUDY ACTIVITY INCLUDED THESE PROJECTS: - "DEVELOPMENT OF ELECTRONIC DENTAL RECORDS (EDR) FOR TRANSLATING RESEARCH INTO PRACTICE" - "EDENT: COMPARATIVE ANALYSIS OF METHODS FOR IMPLEMENTING GUIDELINES INTO DENTAL PRACTICE FOR THE MANAGEMENT OF CHRONIC DISEASE" - "ORAL HEALTH QUALITY OF LIFE: THE SELF-REPORTED IMPACT OF ORAL HEALTH AND DENTAL CARE ON INDIVIDUALS' QUALITY OF LIFE" - "CATI: COMPUTER-ASSISTED TOBACCO INTERVENTION IN DENTAL OFFICES" - "RESTORATIVE FUNCTIONS AUXILIARIES: IMPACT ON THE PRIMARY CARE IN THE ORAL HEALTH DELIVERY SYSTEM" RESEARCH IN SURGERY - THE DEPARTMENT OF SURGERY FOR HEALTHPARTNERS MEDICAL GROUP AND REGIONS HOSPITAL HAS MORE THAN 20 RESEARCH STUDIES UNDER WAY, INCLUDING RESEARCH ON TRAUMA, CRITICAL CARE, EMERGENCY MEDICAL SERVICES, AND BURNS. RESEARCH STARTED IN 2010 INCLUDED AN NIH-FUNDED TRIAL EXAMINING THE USE OF PROGESTERONE IN HEAD-INJURED PATIENTS AND A STUDY EVALUATING VENTILATOR-ASSOCIATED PNEUMONIA IN TRAUMA PATIENTS. RESEARCH CONDUCTED IN 2010 ALSO INCLUDED AN NIH-FUNDED PRE-HOSPITAL STUDY EXAMINING THE USE OF GLUCOSE, INSULIN, AND POTASSIUM IN ACUTE CORONARY SYNDROME PATIENTS, A PROJECT EXAMINING THE PREDICTIVE POWER OF BREATHING VARIABILITY FOR PATIENTS WHO ARE MECHANICALLY VENTILATED, AND THE ABILITY OF PARAMEDICS TO ASSESS SEPSIS IN NURSING HOME PATIENTS. EXTERNAL COLLABORATION THE HMO RESEARCH NETWORK (HMORN) - HPRF IS A MEMBER OF HMORN, A COLLABORATIVE OF 16 RESEARCH CENTERS AFFILIATED WITH INTEGRATED HEALTH CARE SYSTEMS. HPRF AND HMORN RESEARCH INVESTIGATORS HAVE WORKED ON FEDERALLY FUNDED PROJECTS SUCH AS THE HMO CANCER RESEARCH NETWORK, THE VACCINE SAFETY DATALINK, THE CENTER FOR EDUCATION AND RESEARCH IN THERAPEUTICS, THE COORDINATED CLINICAL STUDIES NETWORK, THE CARDIOVASCULAR RESEARCH NETWORK, THE DECIDE NETWORK, AND THE FDA SENTINEL. THE MENTAL HEALTH RESEARCH NETWORK WAS ADDED IN 2010. MENTAL HEALTH RESEARCH NETWORK (MHRN) SINCE INITIAL FUNDING IN JULY 2010, THE FIRST YEAR OF THE MHRN HAS BEEN PRIMARILY WORKING ON UNDERSTANDING VARIATIONS IN THE MENTAL HEALTH DATA IN THE VIRTUAL DATA WAREHOUSE (VDW) IN THE 10 PARTICIPATING ORGANIZATIONS. THE GROUP HAS DEVELOPED A LIST OF INITIAL MENTAL HEALTH CONDITIONS, DRUG CATEGORIES PERTINENT TO THOSE CONDITIONS, AND THE DRUG LIST IN EACH CATEGORY INCLUSIVE OF ALL SITES. THE COLLABORATIVE WORKGROUPS AND STUDY TEAMS ALSO ENGAGED IN WORK ON ALL ACTIVITY SCHEDULED FOR THE FIRST YEAR OF OPERATION AND BEGAN EARLY MANY OF THE ACTIVITIES SLATED TO BEGIN THE SECOND YEAR. AT THE END OF THE FIRST YEAR OF FUNDING, THE COLLABORATIVE HAS ACCOMPLISHED A WIDE RANGE OF ACTIVITIES: - THE VDW WORKGROUP HAS COMPLETED THE FIRST ROUND OF ANALYSES ON DIFFERENCE IN RATES OF EXPOSURE TO BROAD CLASSES OF MEDICATIONS AND CONDITIONS AND HAS BEGUN WORK ON ANALYSES OF DIFFERENCES IN RATES OF DIAGNOSES TO SELECTED MENTAL HEALTH CONDITIONS. - THE HUMAN SUBJECTS CHAIR AND PROJECT MANAGER HAVE BEGUN TO CATALOG INSTITUTIONAL REVIEW BOARD (IRB) PRACTICES, STATE REGULATIONS AND MEDICAL GROUP, HEALTH PLAN AND HOSPITAL PRACTICES REGARDING RESEARCH ACCESS TO AND USE OF MENTAL HEALTH DATA. TWO MEETINGS HAVE BEEN HELD WITH IRB CHAIRS OF MEMBER ORGANIZATIONS TO DISCUSS THE MATERIAL COLLECTED THUS FAR. THE WORK GROUP IS SCHEDULED TO BEGIN MEETING MID-2011 AND WILL ANALYZE THE STATE LAWS AND SITE TRADITIONS IN MENTAL HEALTH RESEARCH, SURVEY INVESTIGATORS AND PROJECT MANAGERS TO IDENTIFY ANY HUMAN SUBJECTS PROTECTION-RELATED ISSUES TO EFFICIENT, EFFECTIVE AND RESPONSIBLE MENTAL HEALTH RESEARCH. THE ULTIMATE GOAL OF THE GROUP IS TO PROVIDE A COMMON UNDERSTANDING OF THE ISSUES AND BEST-PRACTICE APPROACHES TO REDUCE UNNECESSARY VARIABILITY. - THE ASSESSMENT WORK GROUP, SLATED TO BEGIN MID-2011, HAS CREATED AND FIELDED A SURVEY TO IDENTIFY WHAT MENTAL HEALTH RESEARCH LEADERS IN MEMBER AND PARTNER ORGANIZATIONS HAVE BEEN CONDUCTING AND WISH TO CONDUCT AS PART OF FUTURE MHRN ACTIVITIES. THE GROUP IS BUILDING AN ENDNOTE DATABASE WITH ARTICLES ON DEPRESSION, ANXIETY, AND QUALITY OF LIFE AND IS REVIEWING AVAILABLE INFORMATION ABOUT INSTRUMENT VALIDATION, RELIABILITY AND USE IN DIFFERENT CULTURES AND LANGUAGES. - THE AUTISM STUDY GROUP BEGAN WORK ON CREATING A REGISTRY IN JANUARY 2011. THE DATABASE WILL BE USED TO ASCERTAIN AND VALIDATE AUTISM SPECTRUM DISORDER DIAGNOSES AND COMPARE RATES OF PREVALENCE, UTILIZATION PATTERNS AND DEMOGRAPHICS. THE GROUP IS BEGINNING TO DEVELOP A WEB-BASED SURVEY BY IDENTIFYING THE DOMAINS TO BE SURVEYED. - THE PRACTICE VARIATION STUDY GROUP WILL BEGIN MEETING MID-2011. - THE SSRI AND SUICIDALITY STUDY GROUP HELD THEIR KICKOFF MEETING IN MARCH 2011 AND HAVE BEGUN TO REFINE THE STUDY DESIGN. - THE PERINATAL DEPRESSION STUDY GROUP KICKOFF MEETING WAS HELD AT THE HMORN CONFERENCE IN APRIL 2011. GROUP MEMBERS IDENTIFIED THE METHODS BY WHICH THE FOUR SITES WILL EACH IMPLEMENT THE STUDY DESIGN. - THE COLLABORATIVE HAS REVIEWED THE DRAFT IMPLEMENTATION PLAN FOR THE ELEMENTS WITHIN THE EVALUATION CORE AND HAS DETERMINED THAT AN EVALUATION AND ENGAGEMENT COMMITTEE WILL BE FORMED TO DEVELOP SPECIFIC PROPOSALS FOR THE MHRN APPROACH TO PROJECT MANAGEMENT, PRODUCTIVITY, AND STAKEHOLDER ENGAGEMENT. THIS COMMITTEE WILL BEGIN TO MEET IN SPRING 2011. - THE COLLABORATIVE HAS DRAFTED AND BEGUN TO REFINE A POLICY REGARDING MANAGEMENT OF NEW RESEARCH PROPOSALS AND HAS BEGUN TO DISCUSS HOW THE MHRN WILL ENGAGE WITH THE OTHER MEMBERS OF THE COLLABORATORY. THE COLLABORATIVE IS WELL POISED TO ACCOMPLISH ITS SECOND-YEAR GOALS AND EXPECTS ITS NEW WEB SITE, WHICH WILL ENHANCE COMMUNICATION AND EFFICIENCIES AMONG GROUP MEMBERS, TO BE OPERATIONAL MID-2011. | ||
| THE MINI-SENTINEL - THIS IS A COLLABORATIVE INVOLVING SIX OF THE HMORN CENTER FOR EDUCATION AND RESEARCH ON THERAPEUTICS (CERT) SITES JOINED AS A SINGLE ORGANIZATION IN COLLABORATION WITH 19 OTHER NATIONAL CENTERS AND ORGANIZATIONS UNDER THE DIRECTION OF DR. RICHARD PLATT AT HARVARD PILGRIM HEALTH CARE IN RESPONSE TO AN RFP PUBLISHED BY THE U.S. FOOD AND DRUG ADMINISTRATION TO DEVELOP THE SENTINEL INITIATIVE. THE SENTINEL INITIATIVE IS THE OUTCOME OF A 2008 PUBLICATION TITLED THE SENTINEL INITIATIVE: NATIONAL STRATEGY FOR MONITORING MEDICAL PRODUCT SAFETY. THE SPECIFIC GOALS OF THE MINI-SENTINEL PROJECT ARE: - FUNDING A COORDINATING CENTER WITH DIRECT ACCESS TO AUTOMATED HEALTH CARE DATA SYSTEMS - PROVIDING A LABORATORY FOR DEVELOPING AND EVALUATING SCIENTIFIC METHODOLOGIES THAT MIGHT LATER BE USED IN A FULLY-OPERATIONAL SENTINEL INITIATIVE - TO EVALUATE SAFETY ISSUES IN EXISTING AUTOMATED HEALTH CARE DATA SYSTEMS TO LEARN MORE ABOUT THE BARRIERS AND CHALLENGES OF THIS WORK INTERNALLY AND EXTERNALLY CANCER STUDIES - IN 2010, HPRF CONTINUED TO CONDUCT STUDIES LOCALLY AND TO ACTIVELY PARTICIPATE IN THE HMO CANCER RESEARCH NETWORK IN A NATIONAL CANCER INSTITUTE (NCI)-FUNDED COLLABORATION OF 14 HEALTH PLANS NATIONWIDE STUDYING CANCER PREVENTION, DIAGNOSIS, AND TREATMENT: - THE "BREAST CANCER IN OLDER WOMEN" (BOW) PROJECT, A CRN COLLABORATIVE STUDY RECEIVED CONTINUED FUNDING. THIS PROJECT WAS DESIGNED TO ADDRESS THE SURVIVORSHIP RESEARCH PRIORITIES OF THE NCI AND THE INSTITUTE OF MEDICINE TO UNDERSTAND AND REDUCE THE ADVERSE EFFECTS OF CANCER TREATMENT IN OLDER ADULTS. THE BOW STUDY WILL PROVIDE AS MANY AS 15 YEARS OF INFORMATION ON FOLLOW-UP CARE, LATE TREATMENT EFFECTS, AND HEALTH CARE COSTS AMONG SURVIVORS OF BREAST CANCER 65 YEARS OR OLDER. CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE (CTSI) - HPRF IS PART OF THE CTSI, WHOSE GOAL IS TO IMPROVE THE HEALTH OF OUR COMMUNITIES BY INTEGRATING THE UNIVERSITY OF MINNESOTA'S ACADEMIC HEALTH CENTER AND OTHER UNIVERSITY RESOURCES WITH COMMUNITY PARTNERS TO CREATE A COMPREHENSIVE STATEWIDE NETWORK FOR CLINICAL AND TRANSLATIONAL SCIENCE. HPRF'S EXECUTIVE DIRECTOR IS THE CTSI'S POPULATION PROGRAMS DIRECTOR. THROUGH THE CTSI, THESE ORGANIZATIONS AIM TO: - COLLABORATE WITH COMMUNITIES TO IMPROVE HEALTH THROUGH A MODEL THAT CENTERS ON RESEARCH IMPORTANT TO OUR COMMUNITIES - MEET RESEARCHER NEEDS FOR CLINICAL AND TRANSLATIONAL RESEARCH SERVICES THROUGH A SERVICE-ORIENTED RESEARCH PLATFORM - EDUCATE THE NEXT GENERATION OF CLINICAL TRANSLATIONAL SCIENCE RESEARCHERS AND GUIDE CAREER DEVELOPMENT IN CONDUCTING RESEARCH, DEVELOPING COLLABORATIVE, INTERDISCIPLINARY WORK GROUPS, AND IMPLEMENTING FINDINGS INTO PRACTICE SETTINGS CTSI EFFORTS ARE EXPECTED TO ACHIEVE ALIGNMENT WITH MAJOR STATEWIDE HEALTH CARE ORGANIZATIONS AND INSURERS, ELECTRONIC NETWORKS, AND SPECIAL AND RURAL COMMUNITY POPULATIONS, ALONG WITH STRATEGIC INVESTMENTS BY THE UNIVERSITY OF MINNESOTA AND THE STATE OF MINNESOTA TO HAVE A MAJOR STATEWIDE EFFECT ON HEALTH CARE OUTCOMES AND WORKFORCE TRAINING. VACCINE SAFETY DATALINK - THE VACCINE SAFETY DATALINK (VSD) - A COLLABORATION AMONG THE CENTERS FOR DISEASE CONTROL AND PREVENTION, AMERICA'S HEALTH INSURANCE PLANS, AND 8 HMOS, INCLUDING HEALTHPARTNERS, TO MONITOR AND ASSESS THE SAFETY OF CHILDHOOD AND ADULT VACCINES. THE EIGHT HMOS CREATE IDENTICAL DATA SETS OF ALL VACCINE EXPOSURES AND ALL MEDICALLY TREATED ILLNESSES, AS WELL AS DEMOGRAPHIC INFORMATION (EG, DATE OF BIRTH, SEX, RESIDENCE). HPRF RESEARCHERS WERE ACTIVE IN 28 VSD PROJECTS IN 2010, AND HPRF WAS THE LEAD SITE FOR FIVE OF THESE(*): - "H1N1 VACCINE SAFETY IN PREGNANT WOMEN"* - "SAFETY OF THE YELLOW FEVER VACCINE AMONG CHILDREN AND ADULTS"* - "HENOCH SCHONLEIN PURPURA AND MENINGOGOCCAL VACCINE"* - "RAPID CYCLE ASSESSMENT OF ADOLESCENT TETANUS, DIPHTHERIA & PERTUSSIS (TDAP)"* - "INFLUENZA VACCINE SAFETY IN PREGNANT WOMEN"* - "RAPID CYCLE ANALYSIS OF MENINGOCOCCAL CONJUGATE VACCINE SAFETY" - "WHEEZING AND LOWER RESPIRATORY DISEASE (WLRD) MULTISITE STUDY" - "RAPID CYCLE ANALYSIS OF PENTAVALENT ROTAVIRUS (ROTATEQ) VACCINE SAFETY" - "ASSESSMENT OF THE BURDEN OF ROTAVIRUS DISEASE AND IMPACT OF ROTAVIRUS VACCINATION AMONG CHILDREN <5 YEARS OF AGE" - "SAFETY OF TIV IN CHILDREN AGED 24 TO 59 MONTHS" - "INJECTIONS SITE AND LOCAL REACTIONS TO THE FIFTH DIPHTHERIA, TETANUS & PERTUSSIS (DTAP) VACCINATION" - "DOES INFLUENZA VACCINATION IN CHILDREN WITH SICKLE CELL DISEASE RESULT IN AN INCREASED RISK FOR FEVER AND/OR PAIN CRISES?" - "RAPID CYCLE ANALYSIS OF MMR-V VACCINE" - "A SURVEY TO DETERMINE THE ACCURACY OF ADMINISTRATIVE DATA ON INFLUENZA IMMUNIZATION" - "ASSESSMENT OF HUMAN PAPILLOMARVIRUS VACCINE UPTAKE AND COMPLIANCE IN THE VACCINE SAFETY DATALINK" - "RAPID CYCLE ANALYSIS OF HPV VACCINE" - "VACCINATION COVERAGE LEVELS AMONG INFANTS ENROLLED IN MANAGED CARE ORGANIZATIONS (MCOS) PARTICIPATING IN THE VACCINE SAFETY DATALINK PROJECT (VSD)" - "A DESCRIPTIVE STUDY OF VACCINATIONS OCCURRING DURING PREGNANCY" - "THE RATE OF CARDIAC EVENTS FOLLOWING LIVE VIRAL VACCINATIONS IN ADULTS" - "ASSOCIATION OF GUILLIAN-BARR SYNDROME WITH VACCINATION" - "ASSESSMENT OF POSSIBLE ASSOCIATION BETWEEN CHILDHOOD VACCINES AND KAWASAKI SYNDROME" - "ZOSTAVAX SAFETY STUDY IN THE VACCINE SAFETY DATALINK" - "TIV AND THE RISK OF SPONTANEOUS ABORTION: A CASE CONTROL STUDY" - "INFLUENZA VACCINE SAFETY AND PREPARING FOR PANDEMIC FLU VACCINE IMPLEMENTATION" - "SECOND-DOSE VARICELLA VACCINATION AMONG CHILDREN FOLLOWING EXPANSION OF THE ACIP RECOMMENDATIONS: A VACCINE SAFETY DATALINK STUDY" - "RISK OF MEDICALLY ATTENDED EVENTS FOLLOWING ACELLULAR PERTUSSIS VACCINATION IN EARLY CHILDHOOD" - "PARENTS WHO DELAY IMMUNIZATIONS: A FEASIBILITY STUDY FOR EVALUATING SAFETY" CARDIOVASCULAR RESEARCH NETWORK (CVRN) - THE CVRN, WHICH INCLUDES 15 HMORN SITES, WAS LAUNCHED IN 2007 THROUGH FUNDING FROM THE NATIONAL HEART, LUNG, AND BLOOD INSTITUTE. THE CVRN CAPITALIZES ON SEVERAL KEY STRENGTHS OF HMORN, INCLUDING ITS BROAD EXPERTISE IN CARDIOVASCULAR MEDICINE, DIVERSE HEALTH PLANS AND POPULATIONS, AND INTEGRATED DATA SYSTEMS. THE CVRN AIMS TO DEVELOP A FRAMEWORK FOR EXPLORING CRITICAL QUESTIONS IN CARDIOVASCULAR EPIDEMIOLOGY AND THE OPTIMAL MANAGEMENT OF CARDIOVASCULAR DISEASE IN LARGE, COMMUNITY-BASED POPULATIONS. INTERNAL COLLABORATION BOTH PARTNERSHIP GRANTS AND DISCOVERY GRANTS ARE FUNDED BY DONATIONS TO HPRF AND MATCHED BY HEALTHPARTNERS. DISCOVERY GRANTS PROVIDE INTERNAL FUNDING FOR PROJECTS THAT HAVE PROMISE FOR FUTURE EXTERNAL FUNDING, ADDRESS CLINICAL AND/OR ORGANIZATIONAL CONCERNS, INVEST IN A NEW RESEARCHER, AND SUPPORT ORGANIZATIONAL AND CLINICAL LEARNING TO IMPROVE PATIENT CARE OR ENHANCE THE ABILITY TO CONDUCT MEANINGFUL RESEARCH. PARTNERSHIP GRANTS AIM TO FOSTER ACTIVE COLLABORATION BETWEEN RESEARCHERS AND OPERATIONAL LEADERS TO ANSWER CRITICAL QUESTIONS ABOUT EXISTING HEALTH PROGRAMS AND PATIENT CARE ISSUES. THIS RESEARCH MAY EVALUATE OR LEAD TO CHANGES IN THE WAY HEALTHPARTNERS DELIVERS OR ADMINISTERS CARE. BOTH PROGRAMS ACTIVELY SUPPORT THE SHARING OF RESULTS IN THE PUBLIC DOMAIN THROUGH PUBLICATION OF FINDINGS IN PEER-REVIEWED JOURNALS. DISCOVERY GRANTS FUNDED IN 2010: - "HIGH DOSE INSULIN DOSING STUDY IN TOXIC CARDIOGENIC SHOCK" - "AGREEMENT BETWEEN PHYSICIAN AND CT SCAN IN HIGH ENERGY MECHANISM STABLE TRAUMA PATIENTS - A PILOT STUDY" - "DETERMINING THE THICKNESS OF BREAST SKIN FLAPS" - "IDENTIFICATION OF THERAPEUTIC BLOOD AND URINE TETRAHYDRAZOLINE LEVELS IN ADULTS" - "PRIMARY NON-ADHERENCE AND HEALTH CARE UTILIZATION" - "GUIDED IMAGERY FOR HEALTHY SLEEP" - "THE EFFECT OF COMPLETING CARDIAC REHABILITATION THERAPY ON HOSPITAL READMISSION RATES AND PATIENT OUTCOMES" - "DETERMINING VDW SUFFICIENCY OF REGIONS TUMOR REGISTRY DATA" - "ASSOCIATION OF SMALL LDL PARTICLES WITH RHEUMATOID ARTHRITIS: A POSSIBLE MECHANISM FOR INCREASED ATHEROGENESIS" - "AN EVALUATION OF ONLINE COGNITIVE BEHAVIORAL THERAPY FOR INSOMNIA" NO PARTNERSHIP GRANTS WERE FUNDED IN 2010. PUBLICATIONS IN 2010, HPRF RESEARCHERS DISSEMINATED THE RESULTS OF THEIR RESEARCH BY PUBLISHING 151 ARTICLES, BOOKS AND BOOK CHAPTERS, AND BY GIVING 269 PAPER AND POSTER PRESENTATIONS AT NATIONAL AND INTERNATIONAL CONFERENCES. | ||
| FORM 990, PART VI, SECTION A, LINE 6 | THE SOLE CORPORATE MEMBER OF HPRF IS GROUP HEALTH PLAN, INC. (GHI), A MINNESOTA NON-PROFIT CORPORATION RECOGNIZED AS EXEMPT FROM FEDERAL INCOME TAX UNDER IRC SECTION 501(C)(3). | |
| FORM 990, PART VI, SECTION A, LINE 7A | GHI, AS THE SOLE CORPORATE MEMBER, SELECTS AND/OR APPROVES ALL DIRECTORS. | |
| FORM 990, PART VI, SECTION A, LINE 7B | GHI, AS THE SOLE CORPORATE MEMBER APPROVES ACTIONS AS FOLLOWS: - AMENDMENTS TO THE ARTICLES AND BYLAWS - ANNUAL AND CAPITAL BUDGETS AND LONG-RANGE PLANS - UNBUDGETED SPECIAL PROJECTS IN EXCESS OF $10,000 - GUARANTEEING THE DEBT OF ANY OTHER PERSON OR ENTITY - A LOAN OR OTHER INDEBTEDNESS IN EXCESS OF $10,000 - DISPOSITION OF SUBSTANTIALLY ALL ASSETS - MERGER OR CONSOLIDATION WITH ANOTHER CORPORATION - DISSOLUTION - SELECTION OF OFFICERS | |
| FORM 990, PART VI, SECTION B, LINE 11 | HPRF'S 990 RETURN HAS A COMPREHENSIVE REVIEW PROCESS THAT IS FOLLOWED BEFORE IT IS PRESENTED TO THE GOVERNING BODY OF HPRF. THE REVIEW PROCESS INCLUDES A LAYERED REVIEW BY THE TAX DEPARTMENT OF GHI, THE MANAGEMENT TEAM OF HPRF, GHI'S INTERNAL LEGAL DEPARTMENT AND HPRF'S OUTSIDE INDEPENDENT ACCOUNTANTS. EACH ONE OF THOSE AREAS HAS AN OPPORTUNITY TO REVIEW, ASK QUESTIONS AND MAKE COMMENTS BACK TO THE TAX DEPARTMENT OF GHI BEFORE THE FORM 990 IS COMPLETED AND PRESENTED TO THE GOVERNING BODY OF HPRF. ONCE THAT REVIEW PROCESS HAS BEEN COMPLETED, IT IS THE POLICY OF HPRF TO MAKE AVAILABLE TO THE FINANCE AND AUDIT COMMITTEE OF THE BOARD OF DIRECTORS AND THE BOARD OF DIRECTORS OF HPRF A COPY OF THE 990 PRIOR TO THE FILING OF THE 990 RETURN. THIS COPY WILL BE PROVIDED IN THE BOARD PACKET OF A FINANCE AND AUDIT COMMITTEE AND BOARD MEETING PRIOR TO THE FILING OF THE 990 AND WILL BE AN AGENDA ITEM AT A BOARD MEETING. THIS PROCESS WILL BE NOTED AND DOCUMENTED IN THE WRITTEN BOARD MINUTES OF THE MEETING. | |
| FORM 990, PART VI, SECTION B, LINE 12C | HPRF IS GOVERNED BY AN 18 MEMBER BOARD OF DIRECTORS. AS REQUIRED BY THE BYLAWS OF HPRF, THE HPRF BOARD MONITORS POTENTIAL CONFLICTS OF INTEREST ON THE PART OF ITS BOARD MEMBERS, OFFICERS AND KEY EMPLOYEES BY MAINTAINING A CONFLICT OF INTEREST POLICY. UNDER THE POLICY, ALL BOARD MEMBERS, PRINCIPAL OFFICERS, MEMBERS OF A COMMITTEE WITH BOARD DELEGATED POWERS AND KEY EMPLOYEES ANNUALLY ARE PROVIDED WITH A COPY OF THE POLICY AND REQUESTED TO COMPLETE A QUESTIONNAIRE IDENTIFYING ANY POTENTIAL CONFLICTS OF INTEREST. THE GENERAL COUNSEL WILL SUMMARIZE THE FINDINGS FOLLOWING REVIEW OF THE QUESTIONNAIRE AND WILL SUBMIT A REPORT TO THE CHAIR, PRESIDENT AND THE EXECUTIVE DIRECTOR. BOARD AGENDAS AND EXECUTIVE DECISIONS ARE MONITORED IN RELATION TO THIS POLICY. | |
| FORM 990, PART VI, SECTION B, LINE 15 | PROCESS FOR DETERMINING COMPENSATION OF CEO, OTHER OFFICERS AND KEY EMPLOYEES HPRF HAS NO EMPLOYEES. ALL OFFICERS, DIRECTORS AND KEY EMPLOYEES ARE PAID BY GHI, A RELATED ORGANIZATION WHICH HAS AN ANNUAL PROCESS TO REVIEW THE MARKET COMPARABILITY OF THE TOTAL COMPENSATION OF HPRF'S EXECUTIVE DIRECTOR AND ITS OTHER OFFICERS AND MEDICAL DIRECTORS (MD). EACH YEAR, UNDER THE DIRECTION OF THE GHI BOARD OF DIRECTORS' COMPENSATION COMMITTEE (COMPENSATION COMMITTEE), AN ANNUAL TOTAL COMPENSATION MARKET REVIEW IS COMPLETED. THE REVIEW INCLUDES ALL COMPONENTS OF COMPENSATION; BASE SALARY, ANNUAL INCENTIVES, BENEFITS AND PERQUISITES. THE MARKET SURVEY RESULTS ARE PRESENTED TO, REVIEWED BY AND APPROVED BY THE COMPENSATION COMMITTEE. THE COMPENSATION COMMITTEE'S MARKET REVIEW PROCESS AND SUBSEQUENT DECISIONS INCLUDE THE FOLLOWING ELEMENTS: - INDEPENDENT BODY - COMMITTEE MEMBERS COMPLETE AN ANNUAL CONFLICT OF INTEREST SURVEY TO ASSURE THE COMMITTEE MEMBERS' INDEPENDENCE - STAFF IS NOT IN ROOM DURING DELIBERATIONS OR VOTE INCLUDING EXECUTIVE SESSIONS - AUTHORIZED BODY - BOARD OF DIRECTORS HAS DELEGATED TO THE COMPENSATION COMMITTEE THE ACCOUNTABILITY AND AUTHORITY TO REVIEW AND APPROVE THE COMPARABILITY DATA OF ALL OFFICERS AND MEDICAL DIRECTORS - THE BOARD OF DIRECTORS HAS DELEGATED TO THE COMPENSATION COMMITTEE THE ACCOUNTABILITY TO CONDUCT AN ANNUAL PERFORMANCE EVALUATION AND TO DETERMINE THE COMPENSATION OF THE EXECUTIVE DIRECTOR AND OTHER OFFICERS BASED ON THE PERFORMANCE REVIEW AND THE MARKET COMPARABILITY DATA - COMPARABILITY DATA - EVERY THREE YEARS, THE COMPENSATION COMMITTEE RETAINS AN INDEPENDENT COMPENSATION EXPERT TO CONDUCT AN EXTENSIVE MARKET COMPARABILITY SURVEY FOR ALL OFFICERS OF THE ORGANIZATION AS WELL AS ITS MDS. WITH THE INPUT OF THE CONSULTANT, THE COMPENSATION COMMITTEE DETERMINED APPROPRIATE PEER GROUPS INCLUDING BOTH LOCAL AND NATIONAL PEER GROUPS. THE SURVEY CONSIDERS EACH ELEMENT OF TOTAL COMPENSATION AND AGGREGATE TOTAL COMPENSATION. BASED ON THIS DATA, THE COMPENSATION COMMITTEE DETERMINES MINIMUM AND MAXIMUM TOTAL COMPENSATION RANGES FOR EACH OFFICER OR MD. IN INTERIM YEARS, GHI'S HUMAN RESOURCE DEPARTMENT, UNDER THE COMPENSATION COMMITTEE'S DIRECTION USES THE SAME RECOGNIZED THIRD PARTY SALARY SURVEYS TO DETERMINE MEDIAN SALARY STRUCTURE CHANGES AND AVERAGE SALARY INCREASES. BASED ON THIS UPDATED DATA, THE COMPENSATION COMMITTEE DETERMINES THE TOTAL COMPENSATION RANGES FOR EACH OFFICER OR MEDICAL DIRECTOR. - THE ELEMENTS OF TOTAL COMPENSATION ARE SALARY, INCENTIVES, BENEFITS AND PERQUISITES. - PROPER CONTEMPORANEOUS DOCUMENTATION - MINUTES OF THE COMPENSATION COMMITTEE ARE PREPARED AFTER EACH MEETING AND APPROVED AT THE NEXT MEETING. - TOTAL COMPENSATION IS APPROPRIATELY REPORTED ON THE FORM 990 AND ON THE EMPLOYEE'S W-2. | |
| FORM 990, PART VI, SECTION C, LINE 19 | HPRF'S FINANCIAL STATEMENTS AND 990 RETURNS ARE MADE AVAILABLE TO ANY PERSON WHO REQUESTS THE INFORMATION FROM HPRF OR HEALTHPARTNERS, INC. HPRF'S ARTICLES OF INCORPORATION ARE AVAILABLE TO ANY PERSON WHO REQUESTS THE INFORMATION THROUGH THE MINNESOTA SECRETARY OF STATE'S OFFICE. HPRF'S CONFLICT OF INTEREST POLICY WHICH IS THE SAME AS THAT OF IT'S RELATED ORGANIZATIONS, HEALTHPARTNERS, INC. AND GROUP HEALTH PLAN, INC. CAN BE VIEWED THROUGH THE HEALTHPARTNERS.COM WEBSITE. | |
| AVERAGE HOURS PER WEEK - RELATED ORGANIZATION | FORM 990, PART VII, SECTION A, LINE 1A, COLUMN (B) | ALL OFFICERS OF HPRF ARE EMPLOYED AND COMPENSATED BY GHI. THE REPORTED AVERAGE HOURS WORKED ARE BASED ON THEIR TOTAL COMPENSATION FROM ALL RELATED ORGANIZATIONS. |
| CHANGES IN NET ASSETS OR FUND BALANCES: | FORM 990, PART XI, LINE 5: | FASB 136 - BENEFICIAL INTEREST IN NET ASSETS OF REGIONS HOSPITAL FOUNDATION -1,018,541. FASB 124 - FAIR MARKET VALUATION ADJUSTMENT 1,186,023. TOTAL TO FORM 990, PART XI, LINE 5: 167,482. |
| Software ID: | |
| Software Version: |